obesity

Weight-loss injections helped make Novo Nordisk the most valuable company in Europe at one point in 2024. The stock has recently taken a fall, though some analysts still see a big future for its weight loss drugs.

Obesity was not recognized as a disease for a long time, but new medications are bringing hope to the treatment of adiposity.